BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35358966)

  • 21. Immunotherapy of uveal melanoma.
    Bosch JJ
    Dev Ophthalmol; 2012; 49():137-149. PubMed ID: 22042018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and epigenetic insights into uveal melanoma.
    Sharma A; Stei MM; Fröhlich H; Holz FG; Loeffler KU; Herwig-Carl MC
    Clin Genet; 2018 May; 93(5):952-961. PubMed ID: 28902406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraocular tumors in adults: uveal melanoma].
    Mueller AJ; Schaller UC; Klingenstein A; Nentwich MM
    Klin Monbl Augenheilkd; 2010 Mar; 227(3):R29-47; quiz R48. PubMed ID: 20234976
    [No Abstract]   [Full Text] [Related]  

  • 25. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
    Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
    Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.
    Bustamante P; Tsering T; Coblentz J; Mastromonaco C; Abdouh M; Fonseca C; Proença RP; Blanchard N; Dugé CL; Andujar RAS; Youhnovska E; Burnier MN; Callejo SA; Burnier JV
    J Exp Clin Cancer Res; 2021 Jun; 40(1):196. PubMed ID: 34134723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New immunotherapy approaches as the most effective treatment for uveal melanoma.
    Eteghadi A; Ebrahimi M; Keshel SH
    Crit Rev Oncol Hematol; 2024 Feb; 194():104260. PubMed ID: 38199429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biology and management of uveal melanoma.
    Sato T; Han F; Yamamoto A
    Curr Oncol Rep; 2008 Sep; 10(5):431-8. PubMed ID: 18706273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delays in the diagnosis of uveal melanoma and effect on treatment.
    Ah-Fat FG; Damato BE
    Eye (Lond); 1998; 12 ( Pt 5)():781-2. PubMed ID: 10070508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatment modalities for uveal melanoma.
    De Potter P; Shields CL; Shields JA
    Curr Opin Ophthalmol; 1996 Jun; 7(3):27-32. PubMed ID: 10163456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What else can we do for uveal melanoma].
    Li B; Xu XL
    Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
    Goh AY; Layton CJ
    Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Management of Uveal and Conjunctival Melanoma.
    Blum ES; Yang J; Komatsubara KM; Carvajal RD
    Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
    Werdich XQ; Jakobiec FA; Singh AD; Kim IK
    Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OSuvm: An interactive online consensus survival tool for uveal melanoma prognosis analysis.
    Wang F; Wang Q; Li N; Ge L; Yang M; An Y; Zhang G; Dong H; Ji S; Zhu W; Guo X
    Mol Carcinog; 2020 Jan; 59(1):56-61. PubMed ID: 31646691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.
    Chandran SS; Somerville RPT; Yang JC; Sherry RM; Klebanoff CA; Goff SL; Wunderlich JR; Danforth DN; Zlott D; Paria BC; Sabesan AC; Srivastava AK; Xi L; Pham TH; Raffeld M; White DE; Toomey MA; Rosenberg SA; Kammula US
    Lancet Oncol; 2017 Jun; 18(6):792-802. PubMed ID: 28395880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients.
    Damato EM; Damato BE
    Ophthalmology; 2012 Aug; 119(8):1582-9. PubMed ID: 22503229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bilateral uveal melanomas. Five case reports].
    Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latest developments in the biology and management of uveal melanoma.
    Patel SP
    Curr Oncol Rep; 2013 Dec; 15(6):509-16. PubMed ID: 24122445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.